Literature DB >> 21129213

Pulmonary lymphangitic carcinomatosis from squamous cell carcinoma of the cervix.

Rani Kanthan1, Jenna-Lynn B Senger, Dana Diudea.   

Abstract

INTRODUCTION: Pulmonary metastasis presenting as lymphangitic carcinomatosis arising from squamous cell carcinoma (SCC) of the cervix is a rare event. Poorly represented in the literature, this event is associated with a) difficulty in accurate diagnosis, b) grave prognosis, and the c) lack of recognized predisposing risk factors. CASE REPORT: A 50 year-old female presented at our practice with a three-month history of a productive cough associated with dyspnoea and shortness of breath. A chest x-ray and computed tomography (CT) scan revealed multiple bilateral patchy areas with subsegmental atelectasis in both lungs which was investigated with a bronchoscopy, left thoracoscopy, and a left lung biopsy. Pathological examination of the wedge biopsy of the left upper lobe revealed neoplastic sheets of cell disturbed along the septal vessels, perivascular/peribronchial lymphatics, and the subpleural lymphatics. This lymphangitic carcinomatosis was confirmed to be metastatic from SCC of the cervix that had been diagnosed and treated two years ago. She was treated with systemic Carbo/Taxol chemotherapy and corticosteroids as a palliative measure. Despite temporary improvement, she died 13 months later.
CONCLUSION: Pulmonary lymphangitic carcinomatosis is a rare manifestation of metastatic SCC of the cervix. As clinical presentations including radiographic imaging mimics other pulmonary entities, accurate diagnosis remains a challenge. Increased clinical awareness of such patterns of metastases in cervical cancer supported by accurate pathological diagnosis is imperative to guide appropriate therapy in these patients.

Entities:  

Mesh:

Year:  2010        PMID: 21129213      PMCID: PMC3006383          DOI: 10.1186/1477-7819-8-107

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  14 in total

1.  Pulmonary lymphangitic carcinomatosis secondary to cervical carcinoma: a case report.

Authors:  K E Kennedy; W A Christopherson; H J Buchsbaum
Journal:  Gynecol Oncol       Date:  1989-02       Impact factor: 5.482

2.  Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.

Authors:  Harry J Long; Brian N Bundy; Edward C Grendys; Jo Ann Benda; D Scott McMeekin; Joel Sorosky; David S Miller; Lynne A Eaton; James V Fiorica
Journal:  J Clin Oncol       Date:  2005-05-23       Impact factor: 44.544

3.  Pulmonary metastasis from carcinoma of the uterine cervix.

Authors:  M Imachi; N Tsukamoto; T Matsuyama; H Nakano
Journal:  Gynecol Oncol       Date:  1989-05       Impact factor: 5.482

Review 4.  Squamous cell carcinoma of the cervix presenting as lymphangitic carcinomatosis: a case report and review of the literature.

Authors:  Kristina Storck; Marta Crispens; Kevin Brader
Journal:  Gynecol Oncol       Date:  2004-09       Impact factor: 5.482

5.  Thoracic metastases from cervical carcinoma: current status.

Authors:  H D Sostman; R A Matthay
Journal:  Invest Radiol       Date:  1980 Mar-Apr       Impact factor: 6.016

6.  Pulmonary metastases from uterine malignancies: results of surgical resection in 133 patients.

Authors:  Masaki Anraku; Kohei Yokoi; Ken Nakagawa; Takehiko Fujisawa; Jun Nakajima; Hirohiko Akiyama; Yoshihiro Nishimura; Koichi Kobayashi
Journal:  J Thorac Cardiovasc Surg       Date:  2004-04       Impact factor: 5.209

Review 7.  Thoracic manifestations of common nonpulmonary malignancies of women.

Authors:  Mark Avdalovic; Andrew Chan
Journal:  Clin Chest Med       Date:  2004-06       Impact factor: 2.878

8.  Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study.

Authors:  David H Moore; John A Blessing; Richard P McQuellon; Howard T Thaler; David Cella; Jo Benda; David S Miller; George Olt; Stephanie King; John F Boggess; Thomas F Rocereto
Journal:  J Clin Oncol       Date:  2004-08-01       Impact factor: 44.544

9.  Results of chemotherapy for pulmonary metastases of carcinoma of the cervix in patients after primary surgical and radiotherapeutic management.

Authors:  G Panek; K Gawrychowski; P Sobiczewski; P Derlatka; A Danska-Bidzinska; L Gmyrek; M Bidzinski
Journal:  Int J Gynecol Cancer       Date:  2007-04-26       Impact factor: 3.437

10.  Usefulness of p16 for differentiating primary pulmonary squamous cell carcinoma from cervical squamous cell carcinoma metastatic to the lung.

Authors:  Chih-Wei Wang; Tzu-I Wu; Chih-Teng Yu; Yi-Cheng Wu; Yun-Hui Teng; Szu-Ying Chin; Chyong-Huey Lai; Tse-Ching Chen
Journal:  Am J Clin Pathol       Date:  2009-05       Impact factor: 2.493

View more
  6 in total

1.  Gastric and colonic metastasis from cancer cervix: An unusual progression with an uncommon cause of mortality.

Authors:  Ashish Singhal; Shakeel Masood; Charu Mahajan; Rahat Hadi; Shalini Bhalla
Journal:  South Asian J Cancer       Date:  2015 Jan-Mar

2.  Analysis of related risk factors of lung metastasis after laparoscopic radical hysterectomy of cervical cancer.

Authors:  Liu Henglian; Wang Jiajun; Wang Caixia; Lu Gang; Xia Min
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

Review 3.  A review of duodenal metastases from squamous cell carcinoma of the cervix presenting as an upper gastrointestinal bleed.

Authors:  Rani Kanthan; Jenna-Lynn Senger; Dana Diudea; Selliah Kanthan
Journal:  World J Surg Oncol       Date:  2011-09-29       Impact factor: 2.754

4.  Alpha-mangostin induces apoptosis through activation of reactive oxygen species and ASK1/p38 signaling pathway in cervical cancer cells.

Authors:  Chien-Hsing Lee; Tsung-Ho Ying; Hui-Ling Chiou; Shu-Ching Hsieh; Shiua-Hua Wen; Ruey-Hwang Chou; Yi-Hsien Hsieh
Journal:  Oncotarget       Date:  2017-07-18

Review 5.  [Squamous cell carcinoma of the cervix relapsing as an isolated pulmonary metastasis: report of a case and review of literature].

Authors:  Rajae Kanab; Fazoumed El M'rabet; Taoufiq Ameuraoui; Fatoumata Sidibé; Siham Tizniti; Afaf Amarti; Samia Arifi; Nawfal Mellas
Journal:  Pan Afr Med J       Date:  2015-12-16

6.  Sesamin inhibits cervical cancer cell proliferation by promoting p53/PTEN-mediated apoptosis.

Authors:  Tian-Ni Kuo; Chun-Shiang Lin; Guan-De Li; Cheng-Yi Kuo; Shao-Hsuan Kao
Journal:  Int J Med Sci       Date:  2020-08-25       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.